1. Home
  2. NTRA vs CVE Comparison

NTRA vs CVE Comparison

Compare NTRA & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CVE
  • Stock Information
  • Founded
  • NTRA 2003
  • CVE 2009
  • Country
  • NTRA United States
  • CVE Canada
  • Employees
  • NTRA N/A
  • CVE N/A
  • Industry
  • NTRA Medical Specialities
  • CVE Oil & Gas Production
  • Sector
  • NTRA Health Care
  • CVE Energy
  • Exchange
  • NTRA Nasdaq
  • CVE Nasdaq
  • Market Cap
  • NTRA 21.5B
  • CVE 23.5B
  • IPO Year
  • NTRA 2015
  • CVE N/A
  • Fundamental
  • Price
  • NTRA $160.50
  • CVE $13.94
  • Analyst Decision
  • NTRA Strong Buy
  • CVE Strong Buy
  • Analyst Count
  • NTRA 16
  • CVE 4
  • Target Price
  • NTRA $185.56
  • CVE $25.75
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • CVE 14.1M
  • Earning Date
  • NTRA 08-07-2025
  • CVE 07-31-2025
  • Dividend Yield
  • NTRA N/A
  • CVE 3.83%
  • EPS Growth
  • NTRA N/A
  • CVE N/A
  • EPS
  • NTRA N/A
  • CVE 1.05
  • Revenue
  • NTRA $1,831,000,000.00
  • CVE $37,926,044,442.00
  • Revenue This Year
  • NTRA $19.92
  • CVE N/A
  • Revenue Next Year
  • NTRA $16.02
  • CVE N/A
  • P/E Ratio
  • NTRA N/A
  • CVE $13.19
  • Revenue Growth
  • NTRA 51.50
  • CVE 2.85
  • 52 Week Low
  • NTRA $92.14
  • CVE $10.23
  • 52 Week High
  • NTRA $183.00
  • CVE $20.76
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 54.70
  • CVE 45.30
  • Support Level
  • NTRA $159.50
  • CVE $13.56
  • Resistance Level
  • NTRA $170.48
  • CVE $13.91
  • Average True Range (ATR)
  • NTRA 4.85
  • CVE 0.36
  • MACD
  • NTRA -0.50
  • CVE -0.14
  • Stochastic Oscillator
  • NTRA 56.94
  • CVE 1.26

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

Share on Social Networks: